Doctors Note Logo

Published on: 10/1/2026

What a hep B titer test shows, and what a low result means

A hepatitis B titer test measures anti-HBs (hepatitis B surface antibody) levels in your blood to show whether you are protected from the virus, along with markers like HBsAg and anti-HBc that reveal past or current infection. A level of 10 mIU/mL or higher generally indicates immunity, while a result under 10 mIU/mL is considered low or "non-immune," which may mean your vaccine response has waned, you never fully responded to the series, or you need revaccination and further testing. There are several important factors to consider, including your age, immune status, occupation, and which specific markers came back positive or negative, so see below for the complete answer before drawing conclusions about your results.

Because a low titer can mean very different things depending on your health history, vaccination timeline, and any symptoms you may be experiencing, it helps to get clarity on what your body is telling you right now. Take a free, instant, online symptom check to better understand your situation and get guidance on the right next steps, including whether to ask your doctor about a booster dose or additional hepatitis B testing.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

Hepatitis B Titer Test: What It Shows and What a Low Result Means

A hepatitis B titer test measures the level of antibodies your immune system has developed against the hepatitis B virus (HBV). It’s most often used to:

  • Confirm immunity after vaccination
  • Check for protection following past infection
  • Screen healthcare workers, pregnant women, and people at increased risk

Below is an overview of what this test shows, how to interpret your results, and what a low antibody level might mean for you.


1. Understanding the Hep B Titer Test

  1. What exactly is being measured?

    • The test quantifies antibodies called anti-HBs (hepatitis B surface antibodies) in your blood.
    • Results are typically reported in milli–international units per milliliter (mIU/mL).
  2. How the test is done

    • A small sample of blood is drawn from your arm.
    • A laboratory uses assays (for example, enzyme-linked immunosorbent assay, ELISA) to measure antibody concentration.
  3. Why anti-HBs and not antigens?

    • Anti-HBs indicates past vaccination or recovery from infection and implies immunity.
    • HBsAg (hepatitis B surface antigen) would indicate active infection; that’s a different test.

2. When and Why You Might Get a Hep B Titer Test

  • After completing the standard hepatitis B vaccine series (usually three shots over six months) to confirm you developed immunity
  • If you work in healthcare, childcare, emergency services, or other high-risk settings
  • During pregnancy if you have risk factors for HBV
  • After needlestick injuries or other potential exposures to infected blood
  • In newborns of mothers positive for hepatitis B to check if passive antibody transfer occurred

3. Interpreting Your Hep B Titer Result

Your report will generally fall into one of three categories:

  1. Protective (Immune)

    • Anti-HBs ≥ 10 mIU/mL
    • You are considered protected against HBV. No additional doses are typically needed.
  2. Non-responder / Susceptible

    • Anti-HBs < 10 mIU/mL
    • You either did not respond to the vaccine or lost your protective levels over time.
  3. High titer

    • Anti-HBs well above protective threshold (for example, ≥ 100 mIU/mL)
    • No extra action is needed; your immunity is strong.

4. What a Low Result Means

If your anti-HBs level is below 10 mIU/mL, it suggests one of the following:

  • No adequate response to vaccination
    • About 5–10% of healthy adults do not develop enough antibodies after a standard vaccine series.
    • Common in older adults, smokers, people with obesity, or those with certain chronic illnesses.

  • Waning immunity over time
    • Antibody levels can decline over years, though immune memory often persists.
    • In healthy individuals, a drop below 10 mIU/mL does not always mean full loss of protection.

  • Laboratory variability
    • Slight differences in testing methods can influence results around the 10 mIU/mL cutoff.
    • A repeat test may be advised if your level is borderline.


5. Next Steps After a Low Hepatitis B Titer

  1. Booster dose or revaccination

    • Many guidelines recommend giving one additional vaccine dose, then rechecking the titer in 1–2 months.
    • If still low, complete another full vaccine series (three doses spaced over six months).
  2. Assess for factors affecting response

    • Discuss medications (like immunosuppressants) or health conditions (like kidney disease) that may blunt your response.
    • Lifestyle factors (smoking, poor nutrition) can also play a role.
  3. Consider specialized protocols

    • People on dialysis or with HIV may follow different vaccination schedules.
    • Your healthcare provider will tailor recommendations based on your overall health.
  4. Monitor occasionally if you remain at risk

    • Healthcare workers and others with ongoing exposure may need periodic titer checks (for example, every 2–5 years).

6. Limitations of the Titer Test

  • Does not detect active infection: A low anti-HBs doesn’t tell you if you’ve ever been infected. To rule out current or past infection, tests for HBsAg or core antibodies (anti-HBc) are needed.
  • Window period: Right after exposure, you may be infected but not yet have antibodies. A negative titer in that period doesn’t exclude acute infection.
  • Immune memory: Even with low circulating antibodies, your immune system may “remember” HBV and respond quickly on exposure.

7. Practical Tips

  • Schedule your blood draw at least 1–2 months after your last vaccine dose for accurate results.
  • Inform the lab if you’re immunocompromised or on medications that affect immunity.
  • Store vaccination records carefully; your doctor can use them to interpret borderline titers.

8. Speak to a Doctor

A low hepatitis B titer is usually not a medical emergency, but it does mean you may need additional vaccine doses or evaluation of your immune status. Always:

  • Discuss your results and next steps with a qualified healthcare provider
  • Review any underlying health conditions or medications that could affect your immune response
  • Ask about long-term monitoring if you remain at high risk of exposure

If you experience any serious symptoms—such as sudden jaundice, abdominal pain, persistent nausea, or unexplained fatigue—seek medical care promptly or call emergency services. You might also consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help determine if you should see a provider right away.


9. Key Takeaways

  • The hep B titer test measures protective antibodies (anti-HBs) after vaccination or recovery.
  • A level of ≥ 10 mIU/mL is considered protective; < 10 mIU/mL suggests you’re not fully immune.
  • Low results are common in a minority of adults; booster doses or revaccination can usually restore protection.
  • Always interpret your titer in the context of your health history, risk factors, and lab methods.
  • Speak to your doctor for personalized advice, especially if you have ongoing exposure risks or an underlying condition.

Maintaining protective immunity against hepatitis B is straightforward once you understand your titer results. With timely follow-up and the right vaccination strategy, you can ensure you stay protected.

(References)

  • * Moraczewska Z, Madaliński K, Holland PV. Simultaneous presence in serum of HBsAg and anti-HBs of different specificities. Intervirology. 1978;9(3):189-92. doi: 10.1159/000148936. PMID: 412814.

  • * Laure F, Zagury D, Saimot AG, Gallo RC, Hahn BH, Brechot C. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science. 1985 Aug 9;229(4713):561-3. doi: 10.1126/science.2410981. PMID: 2410981.

  • * Lambert-Gardini S, Colarossi GG, Sergiacomi U, Gozzo L, Nuzzolo L. Reduction and disappearance of anomalous fluorescence patterns by means of absorption of HIV and EBV positive sera to guinea pig kidney and calf erythrocytes: a preliminary study. Boll Ist Sieroter Milan. 1988;67(5-6):351-6. PMID: 2856487.

  • * Nechaev VV, Mukomolov SL, Shliakhtenko LI, Mikhaĭlov MI, Zubov SV. [Patients with chronic viral hepatitis as sources of infection]. Zh Mikrobiol Epidemiol Immunobiol. 1988 Apr;(4):32-6. PMID: 2970739.

  • * Bonino F, Recchia S, Ponzetto A, Filippone B, Palla M, Zanetti AR, Ferroni P. A solid-phase enzyme immunoassay (EIA) for detection of HBeAg and anti-HBe. J Immunol Methods. 1980;33(2):195-200. doi: 10.1016/s0022-1759(80)80009-3. PMID: 6768806.

  • * Burrell CJ. Serological markers of hepatitis B infection. Clin Gastroenterol. 1980 Jan;9(1):47-63. PMID: 6994952.

  • * Yan BM, Lee SS. Acute coinfection with hepatitis B and hepatitis C viruses. Can J Gastroenterol. 2005 Dec;19(12):729-30. doi: 10.1155/2005/514813. PMID: 16341313.

  • * Towell V, Cowie B. Hepatitis B serology. Aust Fam Physician. 2012 Apr;41(4):212-4. PMID: 22472681.

  • * Travers CP, Connell J, Thornton L, Keane E, Knowles S, Murphy JF. Follow up of infants born to women with hepatitis B in the National Maternity Hospital. Ir Med J. 2015 May;108(5):147-9. PMID: 26062242.

  • * Cadet MJ. Screening for Hepatitis B: Serology Markers Interpretation. Workplace Health Saf. 2018 Oct;66(10):512. doi: 10.1177/2165079918794707. Epub 2018 Aug 23. PMID: 30136615.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.